MedTrace Logo

Patient Outcomes Following Interval and Delayed Cytoreductive Surgery in Advanced Ovarian Cancer

NCT05523804 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2022-08-31

No results posted yet for this study

Summary

To compare patient outcomes following interval and delayed cytoreductive surgeries and no surgery (neoadjuvant chemotherapy alone) and international variations in access to cytoreductive surgeries in women with advanced stage ovarian cancer.

Conditions

Interventions

PROCEDURE

interval cytoreductive surgery

cytoreductive surgery after 3-4 cycles of chemotherapy

PROCEDURE

delayed cytoreductive surgery

surgery after \>5 cycles of chemotherapy

OTHER

no surgery

no cytoreductive surgery (\>5 cycles of chemotherapy alone)

Sponsors & Collaborators

  • University of Aberdeen

    collaborator OTHER

  • Barts & The London NHS Trust

    collaborator OTHER

  • Queen Mary University of London

    collaborator OTHER

  • NHS Grampian

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-26
Primary Completion
2023-12-31
Completion
2024-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05523804 on ClinicalTrials.gov